Traditional Chinese medicines as immunosuppressive agents
- PMID: 10748958
Traditional Chinese medicines as immunosuppressive agents
Abstract
Introduction: Traditional Chinese Medicines (TCM) have been used for centuries in China to treat various immune-mediated disorders.
Methods: This review focuses on the clinical and experimental studies that have been performed with TCM as immunosuppressive agents for the treatment of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), atopic eczema and solid organ transplantation.
Results: The "thunder god" vine, Tripterygium wilfordii Hook F (TWHf), has been extensively used in China to treat SLE and RA. TWHf not only inhibited mitogen-stimulated lymphoproliferation, but its active derivatives have also been shown to inhibit production of proinflammatory cytokines by monocytes and lymphocytes, as well as prostaglandin E2 production via the cyclooxygenase, COX-2, pathway, a potential mechanism of action in patients with RA. Demethylzelasteral (TZ-93), a triterpenoid isolated from the root cortex of TWHf, the plant alkaloid berbamine, and the hydrophobic extract of a Chinese herbal decoction, CMX-13, were all shown to be active in prolonging allograft survival in experimental animal models of heart, skin and single lung transplants, respectively. There are few well-designed randomised placebo-controlled clinical trials demonstrating the efficacy of TCM in various diseases. Zemaphyte, a decoction of 10 herbs, has been shown to be efficacious in the treatment of atopic dermatitis in both children and adults in two randomised double-blind placebo-controlled trials.
Conclusion: There is both laboratory and clinical evidence that the derivatives of many of these herbs may have significant beneficial immunosuppressive effects, however, concerns of toxicity must also be addressed, as exact dosing of the active derivatives is difficult to achieve with the current prescriptions of TCM.
Similar articles
-
A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety.Rheumatol Int. 2011 Sep;31(9):1123-9. doi: 10.1007/s00296-011-1841-y. Epub 2011 Mar 2. Rheumatol Int. 2011. PMID: 21365177 Review.
-
Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.Cochrane Database Syst Rev. 2013 Aug 11;(8):CD008568. doi: 10.1002/14651858.CD008568.pub2. Cochrane Database Syst Rev. 2013. PMID: 23934958 Review.
-
A potential new treatment for rheumatoid arthritis: thunder god vine.Semin Arthritis Rheum. 1997 Apr;26(5):713-23. doi: 10.1016/s0049-0172(97)80040-6. Semin Arthritis Rheum. 1997. PMID: 9144848 Review.
-
Chinese herbal medicine for atopic eczema.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002291. doi: 10.1002/14651858.CD002291.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002291. doi: 10.1002/14651858.CD002291.pub3. PMID: 15495031 Updated. Review.
-
The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms.J Ethnopharmacol. 2015 Dec 24;176:177-206. doi: 10.1016/j.jep.2015.10.010. Epub 2015 Oct 22. J Ethnopharmacol. 2015. PMID: 26471289 Review.
Cited by
-
Demethylzeylasteral exerts potent efficacy against non-small-cell lung cancer via the P53 signaling pathway.Transl Oncol. 2024 Aug;46:101989. doi: 10.1016/j.tranon.2024.101989. Epub 2024 May 22. Transl Oncol. 2024. PMID: 38781861 Free PMC article.
-
Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells.Cell Death Dis. 2017 Oct 26;8(10):e3133. doi: 10.1038/cddis.2017.529. Cell Death Dis. 2017. PMID: 29072681 Free PMC article.
-
Lymphatic endothelial cells efferent to inflamed joints produce iNOS and inhibit lymphatic vessel contraction and drainage in TNF-induced arthritis in mice.Arthritis Res Ther. 2016 Mar 12;18:62. doi: 10.1186/s13075-016-0963-8. Arthritis Res Ther. 2016. PMID: 26970913 Free PMC article.
-
Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.Sci Rep. 2015 Apr 15;5:9700. doi: 10.1038/srep09700. Sci Rep. 2015. PMID: 26814847 Free PMC article. Clinical Trial.
-
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials.Front Plant Sci. 2015 Aug 25;6:655. doi: 10.3389/fpls.2015.00655. eCollection 2015. Front Plant Sci. 2015. PMID: 26379683 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials